Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Proposes Updates To Peripheral Vascular Atherectomy Devices Guidance

Executive Summary

US regulators are proposing updates to a guidance document they finalized in February for devices used to clear arteries of plaque. The updated language specifically addresses software interoperability, pyrogenicity and certain performance-testing requirements.

You may also be interested in...



FDA Re-Finalizes Peripheral Vascular Atherectomy Devices Guidance After Key Updates

The US agency has finalized an update to a previous guidance on devices used to remove atherosclerotic plaque that addresses new software, pyrogenicity and testing concerns.

Another Catheter Class I Recall, This Time For Vascular Solutions

US regulators have announced a second serious recall for a faulty catheter in the past month. The problem with Vascular Solutions’ catheter seems to be similar to Boston Scientific’s recall earlier this month, where a part of the device may break off and get stuck in the patient.

A Bad Tip: Boston Scientific Recalls Thousands Of Catheters In Class I Recall

Boston Scientific has recalled more than 6,000 angiographic catheters because the tip can fall off and get stuck in patients, potentially causing serious injury or death. The company says customers should immediately stop using the lots associated with the faulty products and return them.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT142421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel